EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSPNYG00000016028
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPNYG00000007737
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPNYG00000001536
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPNYG00000003082
Gene Symbol: LOC102215335
3 Cross references
158 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPNYG00000003133
Gene Symbol: LOC102215624
3 Cross references
157 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSPNYG00000017657
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSPNYG00000004756
Gene Symbol: LOC102212520
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSPNYG00000006056
Gene Symbol: LOXL2
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2-Like

Ensembl ID : ENSPNYG00000002990
Gene Symbol: LOC102194114
2 Cross references
204 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPNYG00000017659
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSPNYG00000015609
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSPNYG00000015929
Gene Symbol: LOC102191974
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).